Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Mol Cancer Res. 2011 Mar 30;9(5):616–625. doi: 10.1158/1541-7786.MCR-11-0052

Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21

Brian J Leibowitz 1, Wei Qiu 1, Hongtao Liu 2, Tao Cheng 3, Lin Zhang 2, Jian Yu 1
PMCID: PMC3096742  NIHMSID: NIHMS283475  PMID: 21450905

Abstract

The role of p53 in tissue protection is not well understood. Loss of p53 blocks apoptosis in the intestinal crypts following irradiation, but paradoxically accelerates gastrointestinal (GI) damage and death. PUMA and p21 are the major mediators of p53-dependent apoptosis and cell cycle checkpoints, respectively. To better understand these two arms of p53 response in radiation-induced GI damage, we compared animal survival, as well as apoptosis, proliferation, cell cycle progression, DNA damage, and regeneration in the crypts of WT, p53 KO, PUMA KO, p21 KO, and p21/PUMA double KO (DKO) mice in a whole body irradiation model. Deficiency in p53 or p21 led to shortened survival but accelerated crypt regeneration associated with massive non-apoptotic cell death. Non-apoptotic cell death is characterized by aberrant cell cycle progression, persistent DNA damage, rampant replication stress and genome instability. PUMA deficiency alone enhanced survival and crypt regeneration by blocking apoptosis, but failed to rescue delayed non-apoptotic crypt death or shortened survival in p21 KO mice. These studies help better understand p53 functions in tissue injury and regeneration, and potentially improve strategies to protect or mitigate intestinal damage induced by radiation.

Keywords: p53, p21, PUMA, cell cycle arrest, apoptosis, irradiation, small intestine, stem cells

Introduction

Exposure to high doses of radiation causes acute gastrointestinal (GI) injury, which is also a significant dose-limiting factor in abdominal and pelvic radiotherapy (1, 2). In contrast to the lethal hematopoietic (HP) injury developed from lower doses of irradiation, which can be rescued by bone marrow transplantation, there is no approved treatment or preventive measure for GI damage (3). Radiation models have been used extensively to understand the DNA damage response and stem cell biology (1, 4, 5). Rapidly renewing tissues such as the GI epithelium, bone marrow and hair follicles undergo extensive apoptosis in response genotoxic stresses including radiation. Loss of p53 protects the hematopoietic system and skin against DNA damage-induced injuries (6, 7), but unexpectedly exacerbates GI damage despite blocked apoptosis (810).

Following genotoxic stress, p53 is stabilized and activates transcriptional programs to restrict inappropriate cell proliferation and maintain genome integrity (11, 12). p53-dependent induction of p21 or PUMA is required for p53-depedent cell cycle arrest or apoptosis following ionizing radiation (IR) in most cell types (12, 13). p21 inhibits several cyclin-dependent kinases (CDKs) to initiate the G1 cell cycle checkpoint, and maintain the G2/M checkpoint in some cells (14). PUMA, a pro-apoptotic BH3-only Bcl-2 family protein, promotes Bax/Bak and mitochondria-dependent apoptosis in various cell types (1519). Selective expression of apoptotic or cell cycle regulators has been proposed as a mechanism in determining cell fate following DNA damage (12, 13). We and others have shown recently that PUMA deficiency improves survival and tissue regeneration following lethal doses of IR by blocking apoptosis in stem and progenitor cells of the small intestine and bone marrow, which is associated with elevated p21 levels (2023).

We hypothesized that the paradoxical role of p53 in radiation-induced intestinal damage may be explained by its major downstream targets that regulate apoptosis and cell cycle arrest independently. To test this hypothesis, we compared animal survival, as well as apoptosis, proliferation, cell cycle progression, DNA damage, and regeneration in the crypts of WT, p53 KO, PUMA KO, p21 KO, and PUMA/p21 DKO mice in a whole body irradiation model. We found that deficiency in p53 or p21 leads to accelerated crypt regeneration but shortened survival, which is associated with massive non-apoptotic cell death resulting from aberrant proliferation of clonogenic cells with persistent DNA damage and genome instability. PUMA deficiency did not rescue delayed non-apoptotic crypt death or shortened survival in p21 KO mice, indicating that that a p21-dependent mechanism is required for the productive regeneration of crypts and improved survival in mice resistant to radiation-induced apoptosis.

Materials & Methods

Mice and treatment

The procedures for all animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh. 7- to 10-week-old PUMA+/+/p21+/+ (WT), PUMA−/− (PUMA KO) (24), p21−/− (p21 KO) (The Jackson laboratory, Bar Harbor, ME), PUMA−/−/p21−/− (DKO) and p53−/− (p53 KO) (The Jackson laboratory) mice were generated from heterozygote breeding. All strains are in or have been back crossed to the C57BL/6 background for more than 10 generations (F10), and litter mates were used for PUMA KO, p21 KO and PUMA/p21 DKO. Mice were housed in micro-isolator cages in a room illuminated from 0700 to 1900 hours (12:12-hr light–dark cycle), with access to water and chow ad libitum. Genotyping of WT, PUMA KO and p53 KO (25) and p21 KO (26) alleles were performed as described. Mice were irradiated at a rate of 76 cGy/min in a 137Cs irradiator (Mark I, JL Shepherd and Associates, San Fernando, CA, USA).

Western blotting

Antibodies used include those against PUMA (ab9643; Abcam, Cambridge, MA), p53 and p21 (sc-6243 and sc-397; Santa Cruz Biotechnology, Santa Cruz, CA), and actin (A5541; Sigma-Aldrich, St. Louis, MO). Tissue lysates were collected from freshly scraped intestinal mucosa as previously described (25).

Tissue processing, histological analysis, TUNEL and BrdU staining and crypt microcolony assay

All mice were injected with 100 mg/kg BrdU (Sigma-Aldrich, St. Louis, MO) 2 hr prior to sacrifice. The intestinal tissues were harvested and processed in bundles as described (20, 27) (Supplemental Material). Histological analysis was performed by hematoxylin and eosin (H&E) staining. Mitoses were scored by visual inspections of H&E sections under microscope at magnification of 600× (28). Normal mitoses contain condensed chromosomes that show even and symmetrical separation and alignment. Aberrant mitoses contain condensed chromosomes with multi-polar spindles, lagging or misaligned chromosomes, anaphase bridges, or micronuclei.

TUNEL and BrdU staining were performed as described (20) (Supplemental Material). In brief, TUNEL staining was performed with the ApopTag Peroxidase Kit or ApopTag Fluorescein In Situ Apoptosis Detection Kit (Chemicon International, Temecula, CA). Complete crypts extending to neighboring villi and containing at least 17 cells along either side with several Paneth cells at the bottom were used for counting in samples collected up to 48 h after irradiation unless indicated otherwise. TUNEL-positive or BrdU-positive cells were scored in 100 crypts/mouse, with a minimum of three mice per group. Data were reported as means ± SEM.

The crypt microcolony assay was used to quantify stem cell survival by counting regenerated crypts in H&E stained cross sections 3 and 4 days post-irradiation (20). More details are found in the Supplemental Material. At least three mice were used in each group and the data are reported as means ± SEM.

Immunohistochemistry (IHC) and immunofluorescence (IF)

The detailed methods of immunostaining for active caspase-3, active caspase-8, γ-H2AX, Phospho-RPA32, p21, and double staining of Phospho-H3/γ-H2AX, Ki67/γ-H2AX, Pan-cytokeratin/TUNEL and Phospho-RPA32/Ki67 are described in the Supplemental Material.

Statistical analysis

Comparisons of the responses were analyzed by one-way ANOVA and Dunnett’s post-hoc test using GraphPad Prism 4 software. The survival data were analyzed by log-rank test using GraphPad Prism 4 software. Differences were considered significant if the probability of the difference occurring by chance was less than 5 in 100 (p < 0.05).

Results

Loss of p53 or p21 leads to shortened survival but early crypt regeneration

Deficiencies in p53, PUMA and p21 have been reported to alter survival following irradiation at doses causing GI syndrome and death in mice (9, 20, 28). These experiments were not always conducted in the same genetic background and used varying doses and delivery rates. To better understand the role of p53 and a possible genetic interaction of PUMA and p21 in radiation-induced GI damage, we generated cohorts of mice that were WT or deficient in p53, PUMA, p21, or PUMA and p21 (PUMA/p21 DKO) in the C57/B6 background, and compared their survival following 15 Gy whole body irradiation (WBI) (Figure 1 A). WT mice survived an average of 7.4 days, while p53 KO mice survived an average of 4.5 days, PUMA KO mice survived an average of 10.6 days, p21 KO mice survived an average of 6.5 days, and PUMA/p21 DKO survived an average of 6.3 days (Figure 1B) (20).

Figure 1. p53 or p21 deficiency led to accelerated death and crypt regeneration following WBI.

Figure 1

A) Validation of mice genotypes by PCR (left) and Western blotting using intestinal mucosal extracts 24 h after IR (right). B) The survival of WT, PUMA KO, p21 KO, PUMA/p21 DKO, and p53 KO mice following 15 Gy WBI. PUMA KO vs. WT, p < 0.0001; DKO vs. WT, p = 0.0174; p21 KO vs. WT, p = 0.0405; and p53 KO vs. WT, p < 0.0001. C) Mice with indicated genotypes were treated with 15 Gy WBI and received 100 mg/kg BrdU by IP injection 2 h prior to sacrifice. Representative images of regenerated crypts identified by BrdU staining (brown) after 72 hr (magnification 100×). D) Quantitation of regenerated crypts 72 h after IR in mice with the indicated genotypes from 6–8 complete circumferences. Values are means ± SEM; n = 3 or more in each group. * indicates p < 0.05, and ** indicates p < 0.01 compared to WT.

Surprisingly, PUMA deficiency failed to extend the survival of p21 KO mice. We have shown earlier that PUMA, but not p53, deficiency improved survival and crypt regeneration 96 hr after IR, while both blocked apoptosis by 24 hr (20). We therefore determined the timing and extent of crypt regeneration using a microcolony assay that monitors the regeneration of single clonogenic cells following IR (1). We found that p53 KO, p21 KO, and PUMA/p21 DKO mice all displayed many regenerated crypts 72 hr after IR, while WT and PUMA KO mice had few or none (Figures 1C, 1D and S1A). No regenerated crypt was found at 48 hr in any genotype (data not shown) (20). By 96 hr, all groups of mice had regenerated crypts, with PUMA KO mice displaying the greatest amount (Figure S1B and S1C). Our results indicate that early crypt regeneration is associated with shortened survival following irradiation, suggesting that cell loss might occur in regenerated crypts via a PUMA-independent or non-apoptotic mechanism.

p53 or p21 deficiency leads to delayed non-apoptotic cell death in the intestinal crypts

We first looked for evidence of cell death by TUNEL in the intestinal crypts. The levels of TUNEL-positive cells remained elevated in p53 KO, p21 KO, and PUMA/p21 DKO mice while sharply decreased in WT and PUMA KO mice 72 hr after IR (Figures 2A, 2B, and S2A). However, the levels of active caspase-3 or caspase-8, markers for apoptosis, were very low and not significantly different among all five groups 72 hr after IR (Figures S3A and 2B). More TUNEL-positive cells were also observed in the crypts of p53 KO, p21 KO, and PUMA/p21 DKO mice 48 hr after IR (Figure S2B and S2C), suggesting extensive non-apoptotic cell death in these otherwise “normal” appearing crypts. Using an epithelial marker pan-cytokeratin, we confirmed that this caspase-independent cell death is largely confined in the intestinal epithelium (Figures 2C and S3B). To better understand the nature of this cell death, we compared TUNEL and active caspase-3 signals in p21 KO and WT mice at 0, 4, 24, 48, 72, and 96 hr after IR (Figure S4A and S4B). TUNEL signals stayed elevated in p21 KO mice at 48 hr and later, but diminished in WT mice while active caspase-3 signals peaked at 4 hr and gradually decreased to a minimum at 72 hr similarly in both groups (Figures 2D and S4A and B). Caspase-8 was also activated by radiation, but declined sharply in both WT and p21 KO crypts from 48 to 72 hr (Figure S4C). Activate caspase-8 signals were less than 0.15 cell/crypt in unirradiated WT or p21 KO mice (data not shown). Therefore, loss of p21 led to elevated non-apoptotic cell death in the crypts 48 hr or later after IR during the regeneration phase (Figure 2D).

Figure 2. p53 or p21 deficiency led to non-apoptotic cell death in the crypts following IR.

Figure 2

A) Mice with the indicated genotypes were treated with 15 Gy WBI and sacrificed at 72 h. Cell death in the crypts was assessed by TUNEL and active caspase-3 staining. Representative images are shown (magnification 400×). B) TUNEL- or active caspase-3-positive cells were counted in 10 400× fields. When crypt structure was largely absent, the area below the villi was considered to be the crypt region. Values are means ± SEM; n = 3 in each group. ** indicates p < 0.01 compared to WT. C) Representative images and quantification of double IF staining for TUNEL (green) and pan-cytokeratin (red) 72 h after 15 Gy (magnification 400×). Values are means ± SEM; n = 3 in each group. ** indicates p < 0.01 compared to WT. D) Quantitation (positive cells/400× field) of active caspase-3 (Cas3*, left) and TUNEL (right) in the crypts of WT and p21 KO mice at 0, 4, 24, 48, 72, and 96 h after 15 Gy. Values are means; n = 3 in each group.

Cell death in the crypts within 24 hr of IR is largely attributed to p53-dependent apoptosis through PUMA induction (1, 20). To rule out a potential impact of p21 deficiency on apoptosis, we compared TUNEL and active caspase-3 staining in the crypts of all five groups of mice. p53 KO, PUMA KO, and PUMA/p21 DKO mice were largely protected from apoptosis as expected (Figure 3). Contrary to a recent study (29), our data suggest that accelerated crypt regeneration in p21 KO mice does not indicate enhanced survival of the stem cells and nor is correlated with better survival (3). The failure of PUMA deficiency to rescue early crypt regeneration and shortened survival of p21 KO mice (Figure 1), suggesting that a p21-dependent mechanism, independent of apoptosis, must explain the differences between p53 KO and PUMA KO mice.

Figure 3. p21 deficiency did not affect PUMA-dependent crypt apoptosis induced by IR.

Figure 3

Mice with the indicated genotypes were treated with 15 Gy WBI and sacrificed after 4 and 24 h. Apoptosis was analyzed by TUNEL and active caspase-3 staining. A) Representative images of TUNEL IF staining in the crypts (magnification 600×). B) Quantitation of TUNEL-positive cells by counting at least 100 crypts. Values are means ± SEM; n = 3 in each group. * indicates p < 0.05, and ** indicates p < 0.01 compared to WT. C) Representative images of active caspase-3 staining in the crypts (magnification 600×). D) Quantitation of caspase-3-positive cells by counting at least 100 crypts. Values are means ± SEM; n = 3 in each group. ** indicates p < 0.01 compared to WT.

The p21-dependent checkpoint and DNA repair in the intestinal crypts after IR

Given the established role of p21 in DNA damage-induced checkpoints, we performed a 2 hr BrdU pulse experiment to monitor S phase entry in the intestinal crypts after IR. DNA synthesis decreased significantly 4 hr after 15 Gy in the WT and PUMA KO (p21-competent) groups, but not in the p21- or p53-deficient groups, indicating a failure of G1 checkpoint activation (Figure 4A). Basal crypt proliferation was similar in all groups (Figure 4A). By 24 hr after IR, the rate of DNA synthesis decreased in all groups, with the p53 KO group maintaining the highest level. In contrast, only a slightly higher rate of DNA synthesis was found in PUMA KO crypt, compared to WT crypts, despite blocked apoptosis (Figures 3 and 4A).

Figure 4. p21 deficiency compromised IR-induced G1/S checkpoint and DNA repair in the intestinal crypts.

Figure 4

Mice with the indicated genotypes were treated with 15 Gy WBI and sacrificed at indicated times. A) Proliferation in the intestinal crypts 0, 4, or 24 h after irradiation was assessed by BrdU staining. Upper, representative images are shown (magnification 400×). Lower, Quantitation of BrdU-positive cells from at least 100 crypts. Values are means ± SEM; n = 3 in each group. * indicates p < 0.05, and ** indicates p < 0.01 compared to WT at the same time point. # indicates p < 0.01 compared to WT 0 h. B) Representative images of γ-H2AX foci in the crypts of WT and PUMA KO mice 4 h after IR (magnification 400×). C) Quantitation of γ-H2AX foci in the crypts of WT and PUMA KO mice at 0, 0.5, 1, 2, 4, and 24 h post-IR, time points not drawn in scale. Values are means; n = 3 in each group. D) Quantitation of nuclear p21 expressing cells in 100 intestinal crypts from WT and PUMA KO mice at 0, 4, 24, and 48 h after IR. Values are means ± SEM; n = 3 in each group. *** indicates p < 0.001 compared to WT.

We reasoned that elevated p21 (Figure 1A) (20) might facilitate DNA repair and subsequent crypt regeneration by restricting DNA synthesis immediately after IR in PUMA KO mice (Figure 4A), and measured DNA double strand breaks by γ-H2AX staining in the crypts (Figure 4B). In the PUMA KO group, γ-H2AX foci peaked within 1 hr, sharply decreased by 2–4 hr. In comparison, γ-H2AX foci peaked around 4 hr in the WT group, coincident with extensive apoptosis (Figure 4C). From 4 to 24 hr, γ-H2AX foci decreased 22% (1.16 to 0.9/crypt) in the WT group with significant apoptosis, but decreased by over 62% (0.8 to 0.5/crypt) in the PUMA KO group with blocked apoptosis (Figures 4C and 3). Elevated p21 expression in the PUMA KO crypts was detected in the stem (CBC) and progenitor (+4–9) cells as early as 4 hr after IR (Figures 4D and S6). These findings suggest that p21 is required for radiation-induced checkpoint activation and DNA repair in the crypts.

p53 or p21 deficiency leads to persistent DNA damage following proliferation

Defective checkpoints and DNA repair are predicted to lead to accumulation of DNA damage and non-apoptotic death in regenerated crypts resulting from unusually rapid rounds of cell division and DNA replication (1). Concurrent with the transition from apoptotic to non-apoptotic cell death between 48 and 72 hr after IR, significantly more double strand breaks were found in p21 KO, PUMA/p21 DKO, and p53 KO crypts. Approximately 30-fold more cells inappropriately progressed through S phase and mitosis in these three groups, compared to the WT or PUMA KO group (Figures 5A and 5B, and S7). Unrepaired double strand breaks in S phase are known to cause stalled DNA-replication forks and cell death if not resolved (4). Consistent with this prediction, the number of cells labeled with phospho-RPA32, a marker for stalled replication forks, increased by over 6-fold in p21- and p53-deficient mice, with many co-expressing Ki67. Fewer phospho-RPA32-positive cells were observed in the PUMA KO group than other groups (Figure 5C and 5D), consistent with enhanced DNA repair (Figure 4C). These results indicate that p53-dependent p21 induction prevents accumulation of DNA damage in the intestinal crypts following IR.

Figure 5. p53 or p21 deficiency led to compromised G2/M checkpoint, replication stress and persistent DNA damage in the intestinal crypts following IR.

Figure 5

Mice with the indicated genotypes were treated with 15 Gy WBI and sacrificed at 48 and 72 h. Cell proliferation and mitosis were analyzed by Ki67 and phospho-H3 (pH3) staining, respectively. The presence of DNA double strand breaks and single stranded DNA at the replication forks were analyzed by phospho-γ-H2AX (γ-H2AX) and phospho-RPA32 (p-RPA32), respectively. A) Quantitation of γ-H2AX and Ki67 double positive cells at 48 and 72 h after IR from 10 400× fields in the area below the villus. B) Quantitation of double γ-H2AX and pH3 positive cells at 48 and 72 h after IR from 10 400× fields in the area below the villus. C) Representative pictures of double IF staining for p-RPA32 and Ki67 (magnification 400×). Dashed circles indicate cells stained positive for both markers. D) Quantification of p-RPA32 (upper), or p-RPA32 /Ki67 double positive cells (lower) in (C). Values are means ± SEM; n = 3 in each group. ** indicates p < 0.01 compared to WT.

p53 or p21 deficiency leads to aberrant mitoses and severe genome instability

Loss of p53 was previously shown to increase “mitotic death” in the crypts 24 hr or later after IR (30). We reasoned that this “delayed” cell death can manifest as aberrant mitoses due to persistent DNA lesions coupled with cell division. Mitosis was suppressed by 60–70% in WT crypts 24 hr after IR, and over two thirds of those seen were abnormal (Figure 6A and 6B). Substantially more mitoses, including 10-fold more abnormal mitoses, were observed in p21- or p53-deficient crypts, consistent with loss of the G2/M checkpoint (Figure 6A and 6B). Common abnormalities included lagging or misaligned chromosomes, anaphase bridges, multi-polar spindles and micronuclei (Figure S8A). Mitosis was completely suppressed 48 hr after IR in all five groups of mice prior to crypt regeneration (data not shown). At 72 hr, significantly more aberrant mitoses were found in the regenerated crypts of p53 or p21- deficient groups compared to the WT or PUMA KO groups, which were dominated by numerous micro-nuclei indicative of severe genome instability (Figures 6C and S8B). These results suggest that “mitotic catastrophe”, characteristic of the p21- or p53-deficient crypt cells following IR, is a form of non-apoptotic cell death, attributable to proliferation with persistent DNA damage.

Figure 6. p53 or p21 deficiency increased aberrant mitoses and genome instability in the intestinal crypts after IR.

Figure 6

Mice with the indicated genotypes were treated with 15 Gy WBI and sacrificed at the indicated times. Mitoses were analyzed on H&E stained sections. A) Examples of normal and aberrant mitoses before or 24 h after IR (magnification 600×) are indicated by an arrow and asterisks, respectively. B) Quantitation of normal and aberrant mitoses by counting at least 100 crypts before or 24 h after IR. Values are means ± SEM; n = 3 in each group. * indicates p < 0.05, ** indicates p < 0.01 compared to WT. C) Quantitation of aberrant mitoses in 20 regenerated crypts 72 h after IR. Values are means ± SEM; n = 3 in each group. ** indicates p < 0.01 compared to WT. D) A model of p53-mediated responses in IR-induced intestinal damage and protection. PUMA deficiency coupled with p21 induction, but not p53 deficiency, facilitates intestinal stem cell survival and regeneration. The p21-dependent mechanisms suppress genome instability and non-apoptotic cell death following radiation.

Discussion

The role of p53 in tissue protection is complex, but not well understood. Using mice deficient in p53, PUMA, p21, or PUMA and p21 (PUMA/p21 DKO), we showed that a paradoxical role of p53 in radiation-induced GI damage can be uncoupled largely through its transcriptional targets PUMA and p21. Induction of PUMA leads to rapid loss of intestinal stem cells and progenitors through apoptosis (20), and induction of p21 suppresses catastrophic regeneration of these cells by facilitating cell cycle arrest and DNA repair. As a result, PUMA/p21 DKO mice phenocopy p53 KO mice, with blocked apoptosis but exacerbated GI damage (Figure 6D). In contrast, p53 protects against chronic intestinal degeneration caused by telomere dysfunction by removing chromosomal-unstable stem cells perhaps through apoptosis, independent of p21 (31, 32). It appears that a dual, and sometimes paradoxical, role of p53 in tissue protection is selectively mediated by its targets, which is influenced by the proliferation demand in a given tissue, stem or progenitor cell reserves, and the extent and nature of the damage. A better understanding of these mechanisms can help protect or heal ailing tissues.

Epithelial damage appears to be the major culprit in acute GI radiation toxicity that involves both apoptotic and less understood non-apoptotic cell death (1, 9, 20, 28). Our data indicate that a failure of both the G1 and G2/M checkpoints in p21- and p53-deficient mice contributes to persistent DNA damage, massive replication stress, rampant mitotic defects, and culminates in early crypt regeneration but widespread non-apoptotic cell death. Earlier studies also reported that loss of p21 increases sensitivity to radiation or DNA damage through induction of cell death or senescence depending on the context (17, 26, 33, 34). Cell death induced by radiation appears to be more important in the intestinal epithelium, which is associated with increased proliferation or aberrant mitosis (17, 34, 35). Similarly, loss of the cdk inhibitor p27 leads to a defective G2/M checkpoint and increases genetic instability in the intestinal crypts following DNA damage (36). Deregulation of additional p53 targets might explain the more severe intestinal damage in p53 KO mice than p21 KO mice. Moreover, deficiency in DNA repair proteins ATM (37), p53BP1 (38), or Poly (ADP-ribose) polymerase-1 (PARP-1) (39) exacerbates radiation-induced crypt damage in mice, supporting the notion that DNA repair is critical for productive intestinal regeneration by suppressing genomic instability and non-apoptotic cell death.

Sub-pools of stem cells were recently proposed to be responsible for normal maintenance or regeneration following injury in rapidly renewing tissues including the GI tract (40). The apoptosis-dependent and -independent mechanisms of p53 have been shown to be differentially regulated in hematopoietic stem and progenitor cells following IR (41, 42). Our earlier work demonstrated that PUMA deficiency provided a better protection against IR-induced apoptosis in the CBCs (43), compared to p53 deficiency (27), consistent with the rapidly-renewing CBCs contributing to crypt regeneration (data not shown). It is possible that intestinal stem cells and progenitors might utilize different components of the DNA damage response machinery in response to irradiation or other cytotoxic agents. Well-defined intestinal stem cell markers and mouse models will help provide a deeper understanding of p53-mediated DNA damage responses important in GI diseases including cancer.

There is currently no effective countermeasure against acute GI damage induced by radiation, and targeting p53 carries a high risk for cancer and is unlikely to be useful in this system (10, 44). Our studies suggest a potential strategy, blocking PUMA-dependent apoptosis helps preserve the stem and progenitor compartments immediately after irradiation, while enhanced DNA repair and genome stability, at least in part via p21, can further aid their productive regeneration (Figure 6D). A number of recent studies support this notion. Blocking PUMA-dependent apoptosis profoundly protects against IR-induced GI and HP damage (2023) or adult stem cell depletion upon p53 activation (45), but carries little risk for spontaneous tumorigenesis and even suppresses IR-induced lymphoma (24, 4648). Small molecule PUMA inhibitors are being developed for radiation and mitigation (49), while small molecule CDK4/6 inhibitors suppressed radiation toxicity in the HP system (50). It would be interesting to see whether these molecules can work together to protect normal tissues against radiation or chemotherapy-induced injury. In addition, activation of non-apoptotic cell death pathways might be exploited in p53 negative tumors to improve the efficacy of radiation or chemotherapy through selective killing of tumor cells (51). Therefore, manipulating PUMA and p21, as opposed to p53, might hold a greater promise in clinical settings by balancing short-term tissue reconstitution and long-term cancer risk (Figure 6D).

Supplementary Material

1

Acknowledgements

We thank Drs. Monica Buchanan and Crissy Dudgeon for critical reading.

Grant support: This work is supported in part by NIH grants UO1-DK085570 (JY, TC, LZ), NIH (U19A1068021 Pilot) (JY), CA129829 (JY), CA106348 (LZ, JY), CA121105 (LZ) and American Cancer Society grants RGS-10-124-01-CCE (JY) and RGS-07-156-01-CNE (LZ). The UO1 grant is part of the Intestinal Stem Cell Consortium, a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases.

Abbreviations

GI

gastrointestinal

HP

hematopoietic

WBI

whole body irradiation

IR

irradiation

ISC

intestinal stem cells

TUNEL

terminal deoxynucleotidyl transferase mediated deoxyuridinetriphosphate nick end labeling

Footnotes

Disclosures: The authors have no conflicts to disclose. All author agreed on the submission.

Author contributions

BJL, designed and performed experiments, analyzed data and wrote the paper.

WQ and HTL, performed experiments and analyzed data.

TC and LZ, provided key reagents and analyzed data.

JY, designed experiments, analyzed data and wrote the paper.

References

  • 1.Potten CS. Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine. Radiat Res. 2004 Feb;161(2):123–136. doi: 10.1667/rr3104. [DOI] [PubMed] [Google Scholar]
  • 2.Greenberger JS. Radioprotection. In Vivo. 2009 Mar–Apr;23(2):323–336. [PMC free article] [PubMed] [Google Scholar]
  • 3.Terry NH, Travis EL. The influence of bone marrow depletion on intestinal radiation damage. Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):569–573. doi: 10.1016/0360-3016(89)90108-9. [DOI] [PubMed] [Google Scholar]
  • 4.Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell. 2007 Dec 14;28(5):739–745. doi: 10.1016/j.molcel.2007.11.015. [DOI] [PubMed] [Google Scholar]
  • 5.Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000 Jan 7;100(1):157–168. doi: 10.1016/s0092-8674(00)81692-x. [DOI] [PubMed] [Google Scholar]
  • 6.Westphal CH, Rowan S, Schmaltz C, Elson A, Fisher DE, Leder P. atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet. 1997 Aug;16(4):397–401. doi: 10.1038/ng0897-397. [DOI] [PubMed] [Google Scholar]
  • 7.Botchkarev VA, Komarova EA, Siebenhaar F, et al. p53 is essential for chemotherapy-induced hair loss. Cancer Res. 2000 Sep 15;60(18):5002–5006. [PubMed] [Google Scholar]
  • 8.Merritt AJ, Potten CS, Kemp CJ, et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 1994 Feb 1;54(3):614–617. [PubMed] [Google Scholar]
  • 9.Komarova EA, Kondratov RV, Wang K, et al. Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice. Oncogene. 2004 Apr 22;23(19):3265–3271. doi: 10.1038/sj.onc.1207494. [DOI] [PubMed] [Google Scholar]
  • 10.Gudkov AV, Komarova EA. The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer. 2003 Feb;3(2):117–129. doi: 10.1038/nrc992. [DOI] [PubMed] [Google Scholar]
  • 11.Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000 Nov 16;408(6810):307–310. doi: 10.1038/35042675. [DOI] [PubMed] [Google Scholar]
  • 12.Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell. 2009 May 1;137(3):413–431. doi: 10.1016/j.cell.2009.04.037. [DOI] [PubMed] [Google Scholar]
  • 13.Yu J, Zhang L. The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun. 2005 Jun 10;331(3):851–858. doi: 10.1016/j.bbrc.2005.03.189. [DOI] [PubMed] [Google Scholar]
  • 14.Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999 Jun 15;13(12):1501–1512. doi: 10.1101/gad.13.12.1501. [DOI] [PubMed] [Google Scholar]
  • 15.Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell. 2001 Mar;7(3):673–682. doi: 10.1016/s1097-2765(01)00213-1. [DOI] [PubMed] [Google Scholar]
  • 16.Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell. 2001 Mar;7(3):683–694. doi: 10.1016/s1097-2765(01)00214-3. [DOI] [PubMed] [Google Scholar]
  • 17.Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1931–1936. doi: 10.1073/pnas.2627984100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ming L, Wang P, Bank A, Yu J, Zhang L. PUMA dissociates Bax and BCL-XL to induce apoptosis in colon cancer cells. J Biol Chem. 2006 June 9;281(23):16034–16042. doi: 10.1074/jbc.M513587200. [DOI] [PubMed] [Google Scholar]
  • 19.Yu J, Zhang L. PUMA, a potent killer with or without p53. Oncogene. 2008 Dec;27 Suppl 1:S71–S83. doi: 10.1038/onc.2009.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Qiu W, Carson-Walter EB, Liu H, et al. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell. 2008 June;2(6):576–583. doi: 10.1016/j.stem.2008.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wu WS, Heinrichs S, Xu D, et al. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell. 2005 Nov 18;123(4):641–653. doi: 10.1016/j.cell.2005.09.029. [DOI] [PubMed] [Google Scholar]
  • 22.Yu H, Shen H, Yuan Y, et al. Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose gamma-irradiation. Blood. 2010 Apr 29;115(17):3472–3480. doi: 10.1182/blood-2009-10-248278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Shao L, Sun Y, Zhang Z, et al. Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation. Blood. 2010 Jun 10;115(23):4707–4714. doi: 10.1182/blood-2009-10-248872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jeffers JR, Parganas E, Lee Y, et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell. 2003;4(Oct):321–328. doi: 10.1016/s1535-6108(03)00244-7. [DOI] [PubMed] [Google Scholar]
  • 25.Wu B, Qiu W, Wang P, et al. p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia-reperfusion. Gut. 2007 May;56(5):645–654. doi: 10.1136/gut.2006.101683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science. 2000 Mar 10;287(5459):1804–1808. doi: 10.1126/science.287.5459.1804. [DOI] [PubMed] [Google Scholar]
  • 27.Qiu W, Leibowitz B, Zhang L, Yu J. Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis. Oncogene. 2009 Dec 7;29:1622–1632. doi: 10.1038/onc.2009.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kirsch DG, Santiago PM, di Tomaso E, et al. p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis. Science. 2010 Jan 29;327(5965):593–596. doi: 10.1126/science.1166202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.George RJ, Sturmoski MA, May R, et al. Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury. Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G245–G254. doi: 10.1152/ajpgi.00021.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Merritt AJ, Allen TD, Potten CS, Hickman JA. Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation. Oncogene. 1997 Jun 12;14(23):2759–2766. doi: 10.1038/sj.onc.1201126. [DOI] [PubMed] [Google Scholar]
  • 31.Begus-Nahrmann Y, Lechel A, Obenauf AC, et al. p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nat Genet. 2009 Oct;41(10):1138–1143. doi: 10.1038/ng.426. [DOI] [PubMed] [Google Scholar]
  • 32.Choudhury AR, Ju Z, Djojosubroto MW, et al. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet. 2007 Jan;39(1):99–105. doi: 10.1038/ng1937. [DOI] [PubMed] [Google Scholar]
  • 33.Wang YA, Elson A, Leder P. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14590–14595. doi: 10.1073/pnas.94.26.14590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Komarova EA, Christov K, Faerman AI, Gudkov AV. Different impact of p53 and p21 on the radiation response of mouse tissues. Oncogene. 2000 Aug 3;19(33):3791–3798. doi: 10.1038/sj.onc.1203717. [DOI] [PubMed] [Google Scholar]
  • 35.Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature. 1996;381:713–716. doi: 10.1038/381713a0. [DOI] [PubMed] [Google Scholar]
  • 36.Payne SR, Zhang S, Tsuchiya K, et al. p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability. Mol Cell Biol. 2008 Jan;28(1):258–268. doi: 10.1128/MCB.01536-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ch'ang HJ, Maj JG, Paris F, et al. ATM regulates target switching to escalating doses of radiation in the intestines. Nat Med. 2005 May 11;5:484–490. doi: 10.1038/nm1237. [DOI] [PubMed] [Google Scholar]
  • 38.Clarke AR, Jones N, Pryde F, Adachi Y, Sansom OJ. 53BP1 deficiency in intestinal enterocytes does not alter the immediate response to ionizing radiation, but leads to increased nuclear area consistent with polyploidy. Oncogene. 2007 Sep 20;26(43):6349–6355. doi: 10.1038/sj.onc.1210457. [DOI] [PubMed] [Google Scholar]
  • 39.Ishizuka S, Martin K, Booth C, et al. Poly(ADP-ribose) polymerase-1 is a survival factor for radiation-exposed intestinal epithelial stem cells in vivo. Nucleic Acids Res. 2003 Nov 1;31(21):6198–6205. doi: 10.1093/nar/gkg840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Li L, Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science. Jan 29;327(5965):542–545. doi: 10.1126/science.1180794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Mohrin M, Bourke E, Alexander D, et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell. 2010 Aug 6;7(2):174–185. doi: 10.1016/j.stem.2010.06.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Milyavsky M, Gan OI, Trottier M, et al. A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell. 2010 Aug 6;7(2):186–197. doi: 10.1016/j.stem.2010.05.016. [DOI] [PubMed] [Google Scholar]
  • 43.Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007 Oct 25;449(7165):1003–1007. doi: 10.1038/nature06196. [DOI] [PubMed] [Google Scholar]
  • 44.Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992;356(6366):215–221. doi: 10.1038/356215a0. [DOI] [PubMed] [Google Scholar]
  • 45.Liu D, Ou L, Clemenson GD, Jr, et al. Puma is required for p53-induced depletion of adult stem cells. Nat Cell Biol. 2010 Oct;12(10):993–998. doi: 10.1038/ncb2100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Villunger A, Michalak EM, Coultas L, et al. p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa. Science. 2003 Nov 7;302(5647):1036–1038. doi: 10.1126/science.1090072. [DOI] [PubMed] [Google Scholar]
  • 47.Michalak EM, Vandenberg CJ, Delbridge AR, et al. Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev. 2010 Aug 1;24(15):1608–1613. doi: 10.1101/gad.1940110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Labi V, Erlacher M, Krumschnabel G, et al. Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes Dev. 2010 Aug 1;24(15):1602–1607. doi: 10.1101/gad.1940210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Mustata G, Li M, Zevola N, et al. Development of Small-Molecule PUMA Inhibitors for Mitigating Radiation-Induced Cell Death. Curr Top Med Chem. 2010 Nov 4; doi: 10.2174/156802611794072641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Johnson SM, Torrice CD, Bell JF, et al. Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. J Clin Invest. 2010 Jul 1;120(7):2528–2536. doi: 10.1172/JCI41402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Finkel E. Does cancer therapy trigger cell suicide? Science. 1999 Dec 17;286(5448):2256–2258. doi: 10.1126/science.286.5448.2256. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES